top of page

Tokyo District Court, Reiwa 7 (Wa) 70141, “Inactivated vaccine preparation” (Presiding Judge Nakashima)

Sep 28
2 min read

Updated: Sep 30

Article information

Article type: Case note

Display and classification checked: 2026-09-30

Categories: Patents

Topics: Support requirement / Inventive step / Claim interpretation

Published on this website: 2026-09-29

Tokyo District Court, Reiwa 7 (Wa) 70141, “Inactivated vaccine preparation” (Presiding Judge Nakashima)

Failure to meet the support requirement (+ lack of inventive step)

“Lactococcus garvieae of a serotype that is neither KG− nor KG+” also includes type III Lactococcus garvieae, observed from 2021 onward.

The specification contains no disclosure whatsoever of a vaccine preparation against streptococcosis caused by type III bacteria, and an inactivated type III vaccine is ineffective against streptococcosis caused by type II bacteria.

The patentee argued that “neither KG− nor KG+” in the invention meant only type II. The court rejected that argument: neither type II nor type III was recognized as a classification at the priority date, so the premise that the phrase was understood to mean type II was lacking.



Updates and corrections

This log starts on 30 September 2026. Display and classification checks are distinct from a review of the legal analysis.

2026-09-30 — Presentation update: added the article type, this change log and a link to consultation options. The existing article text was preserved.


2026-10-01 | Name notation: replaced verified Japanese-script personal names with Roman-letter forms in this English article and its navigation. Legal analysis and original publication date unchanged.

Intellectual property enquiries

Comments


Featured Posts

Recent Posts

Archive
Search by Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square
bottom of page